Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study

BackgroundLymphoma patients hospitalized for chemotherapy are at increased risk of venous thromboembolism (VTE) due to prolonged treatment and bed rest. Early prediction of VTE in this group remains challenging. This study aimed to develop a machine learning-based early warning system (VTE-EWS) tail...

Full description

Saved in:
Bibliographic Details
Main Authors: Tingting Jiang, Zailin Yang, Xinyi Tang, Na Fan, Zuhai Hu, Jieping Li, Tingting Liu, Yu Peng, Shuang Chen, Bingling Guo, Xiaomei Zhang, Yong Chen, Jun Li, Dehong Huang, Jun Liu, Yakun Zhang, Xuefen Liu, Xia Wei, Zhanshu Liu, Haike Lei, Yao Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1566905/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390156537135104
author Tingting Jiang
Zailin Yang
Xinyi Tang
Xinyi Tang
Na Fan
Zuhai Hu
Jieping Li
Tingting Liu
Yu Peng
Shuang Chen
Bingling Guo
Xiaomei Zhang
Yong Chen
Jun Li
Dehong Huang
Jun Liu
Yakun Zhang
Yakun Zhang
Xuefen Liu
Xia Wei
Zhanshu Liu
Haike Lei
Yao Liu
author_facet Tingting Jiang
Zailin Yang
Xinyi Tang
Xinyi Tang
Na Fan
Zuhai Hu
Jieping Li
Tingting Liu
Yu Peng
Shuang Chen
Bingling Guo
Xiaomei Zhang
Yong Chen
Jun Li
Dehong Huang
Jun Liu
Yakun Zhang
Yakun Zhang
Xuefen Liu
Xia Wei
Zhanshu Liu
Haike Lei
Yao Liu
author_sort Tingting Jiang
collection DOAJ
description BackgroundLymphoma patients hospitalized for chemotherapy are at increased risk of venous thromboembolism (VTE) due to prolonged treatment and bed rest. Early prediction of VTE in this group remains challenging. This study aimed to develop a machine learning-based early warning system (VTE-EWS) tailored to these patients.MethodsData from 1,141 lymphoma patients hospitalized for chemotherapy were retrospectively collected across four academic medical centers between February 2020 and February 2024. Twelve clinical variables were included, and six machine learning algorithms were applied to build the VTE-EWS. Models were evaluated for accuracy, sensitivity, specificity, and area under the curve (AUC). Variable importance was assessed using permutation analysis, and a nomogram was created to visualize VTE risk. The system’s performance was compared with the Khorana Score (KS).ResultsThe training set included 799 patients from Chongqing University Cancer Hospital, with 342 patients from three other centers forming the external validation set. In external validation, all six models demonstrated strong predictive performance, with accuracies ranging from 0.71 to 0.87 and AUCs from 0.78 to 0.84. Six key variables—white blood cell count, D-dimer levels, central venous catheter use, age, chemotherapy cycles, and ECOG performance status—were selected for the nomogram to predict VTE risk visually. Patients with a predicted probability >0.7 were classified as high-risk. The VTE-EWS identified more high-risk patients and provided greater clinical benefit than the KS.ConclusionsThe VTE-EWS leverages simple clinical indicators to quickly and visually predict VTE risk, enabling precise and targeted interventions for lymphoma patients hospitalized undergoing chemotherapy.
format Article
id doaj-art-3a4752076e3748cf9faa65bc44ef9937
institution Kabale University
issn 2234-943X
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-3a4752076e3748cf9faa65bc44ef99372025-08-20T03:41:46ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-08-011510.3389/fonc.2025.15669051566905Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort studyTingting Jiang0Zailin Yang1Xinyi Tang2Xinyi Tang3Na Fan4Zuhai Hu5Jieping Li6Tingting Liu7Yu Peng8Shuang Chen9Bingling Guo10Xiaomei Zhang11Yong Chen12Jun Li13Dehong Huang14Jun Liu15Yakun Zhang16Yakun Zhang17Xuefen Liu18Xia Wei19Zhanshu Liu20Haike Lei21Yao Liu22Department of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaSchool of Medicine, Chongqing University, Chongqing, ChinaDepartment of Medical Administration, Chongqing Public Health Medical Center, Chongqing, ChinaSchool of Public Health, Chongqing Medical University, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Oncology, The People’s Hospital of Rongchang District, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaSchool of Medicine, Chongqing University, Chongqing, ChinaDepartment of Oncology, The People’s Hospital of Rongchang District, Chongqing, ChinaDepartment of Hematology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaThe Affiliated Department of Hematology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaChongqing Cancer Multi-Omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Hematology-Oncology, Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing, ChinaBackgroundLymphoma patients hospitalized for chemotherapy are at increased risk of venous thromboembolism (VTE) due to prolonged treatment and bed rest. Early prediction of VTE in this group remains challenging. This study aimed to develop a machine learning-based early warning system (VTE-EWS) tailored to these patients.MethodsData from 1,141 lymphoma patients hospitalized for chemotherapy were retrospectively collected across four academic medical centers between February 2020 and February 2024. Twelve clinical variables were included, and six machine learning algorithms were applied to build the VTE-EWS. Models were evaluated for accuracy, sensitivity, specificity, and area under the curve (AUC). Variable importance was assessed using permutation analysis, and a nomogram was created to visualize VTE risk. The system’s performance was compared with the Khorana Score (KS).ResultsThe training set included 799 patients from Chongqing University Cancer Hospital, with 342 patients from three other centers forming the external validation set. In external validation, all six models demonstrated strong predictive performance, with accuracies ranging from 0.71 to 0.87 and AUCs from 0.78 to 0.84. Six key variables—white blood cell count, D-dimer levels, central venous catheter use, age, chemotherapy cycles, and ECOG performance status—were selected for the nomogram to predict VTE risk visually. Patients with a predicted probability >0.7 were classified as high-risk. The VTE-EWS identified more high-risk patients and provided greater clinical benefit than the KS.ConclusionsThe VTE-EWS leverages simple clinical indicators to quickly and visually predict VTE risk, enabling precise and targeted interventions for lymphoma patients hospitalized undergoing chemotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2025.1566905/fullvenous thromboembolismmachine learninglymphomapredictionearly warning
spellingShingle Tingting Jiang
Zailin Yang
Xinyi Tang
Xinyi Tang
Na Fan
Zuhai Hu
Jieping Li
Tingting Liu
Yu Peng
Shuang Chen
Bingling Guo
Xiaomei Zhang
Yong Chen
Jun Li
Dehong Huang
Jun Liu
Yakun Zhang
Yakun Zhang
Xuefen Liu
Xia Wei
Zhanshu Liu
Haike Lei
Yao Liu
Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
Frontiers in Oncology
venous thromboembolism
machine learning
lymphoma
prediction
early warning
title Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
title_full Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
title_fullStr Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
title_full_unstemmed Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
title_short Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study
title_sort development and validation of a machine learning based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy a multicenter and retrospective cohort study
topic venous thromboembolism
machine learning
lymphoma
prediction
early warning
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1566905/full
work_keys_str_mv AT tingtingjiang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT zailinyang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT xinyitang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT xinyitang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT nafan developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT zuhaihu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT jiepingli developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT tingtingliu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT yupeng developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT shuangchen developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT binglingguo developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT xiaomeizhang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT yongchen developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT junli developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT dehonghuang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT junliu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT yakunzhang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT yakunzhang developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT xuefenliu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT xiawei developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT zhanshuliu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT haikelei developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy
AT yaoliu developmentandvalidationofamachinelearningbasedearlywarningsystemforpredictingvenousthromboembolismriskinhospitalizedlymphomapatientsundergoingchemotherapyamulticenterandretrospectivecohortstudy